OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH SEAL WITH HEPARIN— 510(k) K062999

Substantially Equivalent

Hospira, Inc.

FDA 510(k) clearance K062999 for OPTICATH CENTRAL VENOUS OXIMETRY PROBE WITH SEAL WITH HEPARIN, Substantially Equivalent on 2006-11-03. Applicant: Hospira, Inc..

Clearance details

Applicant: Hospira, Inc.
Product code: Code DQE
Advisory panel: Cardiovascular
Date received: 2006-10-02
Decision date: 2006-11-03
Decision: Substantially Equivalent
Clearance type: Special
Location: Lake Forest, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.